Even at an AZD1775 concentration of just 100nM, caspase 3 displayed an upward trend in all endometrial cancer cell lines, suggesting that AZD1775 can induce tumor cell apoptosis to exert antitumor effects, even at relatively low concentrations. Here, CASP3 is linked to neoplasm.